金城医药：第六届董事会第二十次会议决议公告

Core Viewpoint - Jincheng Pharmaceutical announced the approval of a supplementary agreement by its sixth board of directors during the 20th meeting [2] Group 1 - The company held its 20th meeting of the sixth board of directors [2] - The meeting resulted in the approval of a proposal regarding the signing of a supplementary agreement [2]